Clinical Trials
7 trialsNCT04989283 2023-09-26
Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT05935774 2023-08-25
OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
University of Washington
Phase 2 Withdrawn
NCT05007769 2021-11-05
RAN
Washington University School of Medicine
Phase 2 Withdrawn
NCT04611776 2021-06-16
CATHAYA
Hoffmann-La Roche
Phase 2 Withdrawn
NCT04267237 2021-02-04
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer
Hoffmann-La Roche
Phase 2 Withdrawn
NCT03498222 2020-02-25
iTRAP
Queen Mary University of London
Phase 1 Withdrawn
NCT02495636 2017-06-22
Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer
Yale University
Phase 2 Withdrawn